Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,764 public trials 2,078 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05789069

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • New Experimental Therapeutics of Virginia - NEXT Oncology Fairfax, Virginia, United States
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples, Italy
View Trial Details
Active, Not Recruiting

CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

NCT04322955

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • The Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Columbia University Irving Medical Center New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

NCT01953588

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 860 locations
View Trial Details
Active, Not Recruiting

Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma

NCT05784012

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +17 more
Locations
  • Institut Catalá d'Oncologia (ICO) BADALONA Badalona, Catalonia, Spain
  • Hospital Universitario Valle Hebron Barcelona, Catalonia, Spain
  • Hospital Clinic de Barcelona Barcelona, Catalonia, Spain
  • Institut Catalá d'Oncologia (ICO) Hospitalet L'Hospitalet de Llobregat, Catalonia, Spain
View Trial Details
Active, Not Recruiting

MAGE-A4ᶜ¹º³²T for Multi-Tumor

NCT03132922

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +67 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma

NCT02780310

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma

NCT02519348

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site San Francisco, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Jacksonville, Florida, United States
View all 44 locations
View Trial Details

Related conditions